featured
Risk of Priapism With Oral PDE5 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Sexual Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Are We Overstating the Risk of Priapism With Oral Phosphodiesterase Type 5 Inhibitors?
J Sex Med 2020 Jul 01;[EPub Ahead of Print], ME Rezaee, MS GrossFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.